Kobara Miyuki | Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
スポンサーリンク
概要
関連著者
-
Katamura Maki
AMI-Kyoto Multi-Center Risk Study Group
-
Katamura Maki
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Matsubara Hiroaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Matsubara Hiroaki
Department Of Cardiology Kyoto Prefectural University Of Medicine
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Nakata Tetsuo
Department Of Cardiovascular Medicine Nantan General Hospital
-
Nakamura T
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Kobara Miyuki
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
Tatsumi Tetsuya
Department Of Cardiovascular Medicine Nantan General Hospital
-
TATSUMI Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Shiraishi Jun
Department Of Cardiology Kyoto First Red Cross Hospital
-
Furukawa Keizo
Department of Cardiology, Kyoto City Hospital
-
Yamada Hiroyuki
Ami-kyoto Multi-center Risk Study Group
-
Matsumoto Takashi
Department Of Cardiology Kyoto First Red Cross Hospital
-
Sawada Takahisa
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Shiraishi Jun
Department of Cardiology, Kyoto First Red Cross Hospital
-
Kohno Yoshio
Department of Cardiology, Kyoto First Red Cross Hospital
-
Yokoi Hirokazu
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tatsumi Tetsuya
京都第一赤十字病院 循環器科
-
Okada Takashi
Department of Cardiology, Kyoto First Red Cross Hospital
-
Tatsumi Tetsuya
Kyoto Prefectural University Of Medicine
-
Makino H
Department Of Medicine And Clinical Science Okayama University Graduate School Of Medicine And Denti
-
KEIRA Natsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Matoba Satoaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
NISHIKAWA Susumu
Department of Cardiovascular Medicine, Nantan General Hospital
-
Nishikawa Susumu
Department Of Cardiovascular Medicine Nantan General Hospital
-
Nakamura Takeshi
Department Of Cardiovascular Medicine Nantan General Hospital
-
Matsuo Akiko
Department Of Cardiology Kyoto First Red Cross Hospital
-
Matsuoka Hiroaki
大阪大学 医学系研究科老年・腎臓内科学
-
Takai Shinji
Department Of Cardiology Kouseikai Takeda Hospital
-
Nakamura Takeshi
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Shiga Koji
AMI-Kyoto Multi-Center Risk Study Group
-
Katoh S
Ami-kyoto Multi-center Risk Study Group
-
AZUMA Akihiro
Department of Cardiology, National Shiga Hospital
-
Miyanaga Hajime
AMI-Kyoto Multi-Center Risk Study Group
-
Yamada Chihiro
AMI-Kyoto Multi-Center Risk Study Group
-
Mano Akiko
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Muratani H
Department Of Clinical Pharmacology And Therapeutics Tohoku University
-
Furukawa Keizo
AMI-Kyoto Multi-Center Risk Study Group
-
Kitamura Makoto
AMI-Kyoto Multi-Center Risk Study Group
-
Matsunaga Shinsaku
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Azuma Akihiro
松下電器健康保険組合松下記念病院
-
Muratani Hiromi
琉球大学 第3内科
-
Metoki Hirohito
東北大学 臨床薬学
-
Shima Takatomo
Department of Cardiology, Kyoto First Red Cross Hospital
-
Kimata Masaki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Hayashi Hironori
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
YAMADA Hiroyuki
Department of Materials Engineering, Graduate school of Engineering, The University of Tokyo
-
Kitamura Makoto
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Azuma A
Department Of Cardiology National Shiga Hospital
-
Hyogo Masayuki
Kyoto First Red Cross Hospital
-
Hyogo Masayuki
Department Of Cardiology Kyoto Prefectural University School Of Medicine
-
Matsumuro Akiyoshi
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Yamahara Yasuhiro
AMI-Kyoto Multi-Center Risk Study Group
-
Kohno Yoshio
AMI-Kyoto Multi-Center Risk Study Group
-
Yasue H
Kumamoto Univ. School Of Medicine
-
Hyogo Masayuki
Department Of Cardiology Kyoto Second Red Cross Hospital
-
Yasue H
Division Of Molecular And Genetic Medicine Department Of Genetic Medicine And Regenerative Therapeut
-
MANO Akiko
Department of Organ Transplantation, National Cardiovascular Center
-
Matsubara Hiroaki
公立南丹病院 循環器内科
-
Okada Takashi
AMI-Kyoto Multi-Center Risk Study Group
-
Nakagawa Masao
Second Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Shiraishi Jun
Second Department of Medicine, Kyoto Prefectural University of Medicine
-
Tatsumi Tetsuya
Second Department of Medicine, Kyoto Prefectural University of Medicine
-
Yagi Takakazu
Kyoto First Red Cross Hospital
-
Hyogo Masayuki
Department Of Cardiology Kyoto First Red Cross Hospital
-
Nakagawa Masao
京都府立医科大学 内科学第2
-
Nakagawa Masao
Second Department Of Medicine Kyoto Prefectural University Of Medicine
-
Ito Kazuki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Kuriyama Takuya
AMI-Kyoto Multi-Center Risk Study Group
-
Harada Yoshiaki
AMI-Kyoto Multi-Center Risk Study Group
-
Sakai Ryuta
AMI-Kyoto Multi-Center Risk Study Group
-
Okigaki Mitsuhiko
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Shiraishi Jun
AMI-Kyoto Multi-Center Risk Study Group
-
Hori Masatsugu
大阪大学 大学院医学系研究科内科系臨床医学専攻核医学講座
-
Okigaki Mitsuhiko
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Matsubara Hiroaki
京都府立医科大学 循環器内科学
-
Kitamura Makoto
Kyoto Second Red Cross Hospital
-
Matsuo H
Department Of Internal Medicine Circulatory And Body Fluid Regulation Faculty Of Medicine University
-
Honsho Shoken
Department of Experimental Therapeutics, Translational Research Center, Kyoto University Hospital
-
Tanaka Shiro
大阪市立総合医療センター
-
Tanaka Shiro
Department Of Internal Medicine Osaka City General Hospital
-
Inoue Miho
Ami-kyoto Research Group
-
Nakagawa Masao
Kyoto Prefectural University Of Medicine
-
Tanaka Nana
Department Of Clinical Pharmacology Kyoto Pharmaceutical University
-
Hadase Mitsuyoshi
Department of Cardiology, Saiseikai Shigaken Hospital
-
KINOSHITA Noriyuki
Department of Cardiology, Kouseikai Takeda Hospital
-
NOMURA Tetsuya
Department of Cardiovascular Medicine, Nantan General Hospital
-
Shirayama Takeshi
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Kinoshita Noriyuki
AMI-Kyoto Multi-Center Risk Study Group
-
Nishio Manabu
AMI-Kyoto Multi-Center Risk Study Group
-
Kimura Shinzo
AMI-Kyoto Multi-Center Risk Study Group
-
Nakamura Hideo
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Makino Hirofumi
Okayama Univ. Graduate School Of Medicine Dentistry And Pharmaceutical Sci. Okayama Jpn
-
Mokuno Hiroshi
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
TANAKA Takuya
Department of Chemical Science and Engineering, Graduate School of Engineering, Kobe University
-
Horio Masaru
大阪大学 医学系研究科内科学講座腎臓内科
-
Hoshikawa Yoshiko
鳥取大学 医学系研究科遺伝子医療学
-
Azuma Akihiro
康生会武田病院 循環器科
-
Hadase Mitsuyoshi
Kyoto First Red Cross Hospital
-
Horio Masaru
大阪大学 医学系研究科老年・腎臓内科学
-
Uemura Shiro
First Department of Medicine, Nara Medixal University
-
Okayama Satoshi
First Department of Medicine, Nara Medixal University
-
Horii Manabu
First Department of Medicine, Nara Medixal University
-
UMEMURA Satoshi
Yokohama City University
-
takahashi tomosaburo
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
NAKAMURA Reo
Department of Cardiology, Kouseikai Takeda Hospital
-
IRIE Hidekazu
Department of Cardiology, Kouseikai Takeda Hospital
-
Matsui Akihiro
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Tatsumi Tetsuya
AMI-Kyoto Multi-Center Risk Study Group
-
Iwai-kanai Eri
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Hoshino Atsushi
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Nakaoka Mikihiko
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Hiraumi Yoshimi
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Takahashi Tomosaburo
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Tateishi Kento
Translational Research Center, Kyoto University
-
Okayama Satoshi
First Department Of Internal Medicine Nara Medical University
-
Uemura Shiro
First Department Of Internal Medicine Nara Medical University
-
Horii Manabu
First Department Of Internal Medicine Nara Medical University
-
Umemura Satoshi
日本大学 医学部内科学系腎臓高血圧内分泌内科
-
Osako Motohiko
Department Of Cardiovascular Medicine Kyoto Prefectural University Of Medicine
-
Tateishi Kento
Department of Cardiology, Japan Red Cross Kyoto Daini Hospital
-
Takahashi Tomosaburou
Department Of Cardiovascular Medicine Kyoto Prefectural University School Of Medicine
-
Takeda Mitsuo
Department of Cardiology, Kyoto Prefectural University School of Medicine
-
Sawada Takahisa
AMI-Kyoto Multi-Center Risk Study Group
-
Arihara Masayasu
AMI-Kyoto Multi-Center Risk Study Group
-
Hyogo Masayuki
AMI-Kyoto Multi-Center Risk Study Group
-
Yagi Takakazu
AMI-Kyoto Multi-Center Risk Study Group
-
Shima Takatomo
AMI-Kyoto Multi-Center Risk Study Group
-
Nakamura Takeshi
AMI-Kyoto Multi-Center Risk Study Group
-
Matoba Satoaki
AMI-Kyoto Multi-Center Risk Study Group
-
Shirayama Takeshi
AMI-Kyoto Multi-Center Risk Study Group
-
Matsubara Hiroaki
AMI-Kyoto Multi-Center Risk Study Group
-
KIMURA Masayoshi
Department of Cardiology, Kyoto First Red Cross Hospital
-
Yokote Hiroyuki
The Chemo-Sero-Therapeutic Research Institute
-
Nakamura Reo
Department Of Cardiology Kouseikai Takeda Hospital
-
Azuma Akihiro
Second Department of Medicine, Kyoto Prefectural University of Medicine
-
Kohno Yoshio
Kyoto First Red Cross Hospital
-
Matsubara Hiroaki
京都第一赤十字病院 循環器科
-
Muratani H
Univ. Rykyus School Of Medicine Okinawa Jpn
-
Yasui Toshihide
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Koide Masahiro
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Matsui Hiroyuki
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
-
Hori Masatsugu
大阪大学 医学系研究科循環器内科学
-
Matsuda Hikaru
Cardiovascular Division Osaka Polici Hospital
-
Matsumoto Takashi
Department of Gynecologic Oncology, Shikoku Cancer Center
-
Saito Yoshihiko
First Department of Medicine, Nara Medixal University
-
MATSUBARA Hiroaki
Kyoto Prefectural University of Medicine
-
URA Nobuyuki
Teine Keijinkai Hospital
-
Ariyoshi Makoto
Department of Cardiology, Kyoto City Hospital
-
URAKABE Yota
Department of Cardiovascular Medicine, Nantan General Hospital
-
Nishizawa Shinya
Department of Cardiolgy, Kyoto Prefectural University of Medicine
-
Saji Hideo
Department Of Patho-functional Bioanalysis Graduate School Of Pharmaceutical Sciences Kyoto Universi
-
Katsume Asako
Department of Cardiology, Kyoto Prefectual University of Medicine
-
Urao Norifumi
Department of Cardiovascular Medicine, Kyoto Prefectural University School of Medicine
-
Ashihara Eishi
Department of Transfusion Medicine and Cell Therapy (E.A., T.M.), Kyoto University Hospital
-
Ashihara Eishi
Department Of Transfusion Medicine And Cell Therapy (e.a. T.m.) Kyoto University Hospital
-
Ashihara E
京都府立医科大学 第2内科学
-
Ashihara Eishi
Department Of Transfusion Medicine And Cell Therapy Kyoto University Hospital
-
Ashihara Eishi
Department Of Cardiovascular Medicine Graduate School Of Medicine Kyoto Prefectural University Of Me
-
Horii Manabu
First Department Of Medicine Nara Medical University
-
Ura Nobuyuki
Second Department Of Internal Medicine Sapporo Medical University School Of Medicine
-
Ura Nobuyuki
Second Department Of Internal Medicine Sapporo Medical Unversity School Of Medicine
-
Ura Nobuyuki
大阪大学 医学系研究科老年腎臓内科学
-
Makino Hirofumi
岡山大学 医歯学総合研究科腎・免疫・内分泌代謝内科学
-
Makino Hirofumi
大阪大学 医学系研究科老年・腎臓内科学
-
Masaki Hiroya
The Cardiovascular Center Kansai Medical University
-
Inoue Miho
Department of Biomaterials and Biomimetics, College of Dentistry, New York University
-
Okigaki Mitsuhiko
京都府立医科大学 循環器・腎臓内科学
-
Umemura S
Department Of Internal Medicine And Cardiorenal Medicine Yokohama City University Graduate School Of
-
Hyogo Masayuki
Department of Cardiology, Kyoto Second Red Cross Hospital
-
Ashihara E
Department Of Transfusion Medicine And Cell Therapy Kyoto University Hospital
-
Horio Masaru
琉球大学医学部附属病院 血液浄化療法部
-
SAWADA Takahisa
Kyoto Prefectural University of Medicine, Department of Cardiology
-
Kido Atsumichi
Department of Cardiovascular Medicine, Nantan General Hospital
-
Takeda Mitsuo
AMI-Kyoto Multi-Center Risk Study Group
-
Furukawa Keizo
AMl-Kyoto Multi-Center Risk Study Group
-
Miyanaga Hajime
AMl-Kyoto Multi-Center Risk Study Group
-
Kitamura Makoto
AMl-Kyoto Multi-Center Risk Study Group
-
Yamada Chihiro
AMl-Kyoto Multi-Center Risk Study Group
-
Tatsumi Tetsuya
AMl-Kyoto Multi-Center Risk Study Group
-
Kuriyama Takuya
AMl-Kyoto Multi-Center Risk Study Group
-
Shiga Koji
AMl-Kyoto Multi-Center Risk Study Group
-
Harada Yoshiaki
AMl-Kyoto Multi-Center Risk Study Group
-
Yamahara Yasuhiro
AMl-Kyoto Multi-Center Risk Study Group
-
Sakai Ryuta
AMl-Kyoto Multi-Center Risk Study Group
-
Katamura Maki
AMl-Kyoto Multi-Center Risk Study Group
-
Kinoshita Noriyuki
AMl-Kyoto Multi-Center Risk Study Group
-
Keira Natsuya
AMl-Kyoto Multi-Center Risk Study Group
-
Nishio Manabu
AMl-Kyoto Multi-Center Risk Study Group
-
Kimura Shinzo
AMl-Kyoto Multi-Center Risk Study Group
-
Kido Atsumichi
First Department Of Internal Medicine Nara Medical University
-
ARIHARA Masayasu
Department of Emergency Medicine, Kyoto First Red Cross Hospital
-
MATSUMURO Akiyoshi
Emergency Medicine, Kyoto Prefectural University School of Medicine
-
Tatsumi Tetsuya
Nantan General Hospital
-
Metoki Hirohito
Department Of Clinical Pharmacology And Therapeutics Tohoku University Graduate School Of Pharmaceut
-
Kido Atsumichi
Department Of Cardiology Cardiovascular Center Kosekai Takai Hospital
-
Kido Atsumichi
Department Of Cardiology Nantan General Hospital
-
Ishibashi Kazuya
Department of Cardiology, Kyoto Prefectural Yosanoumi Hospital
-
Matsui Yoshihiro
Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine
著作論文
- PJ-383 Predictors of In-Hospital Prognosis after Primary Percutaneous Coronary Intervention for Repeat Myocardial Infarction : Insights from the AMI-Kyoto Multi-Center Risk Study(PJ065,ACS/AMI (Clinical/Treatment) 3 (IHD),Poster Session (Japanese),The 73r
- PE-460 Prehospital Delay Time and the Rate of Ambulance User for Acute Myocardial Infarction were not Improved from 2000-2007 in Kyoto(PE077,ACS/AMI (Clinical/Diagnosis) 1 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese C
- PE-448 Hypoxia-Induced p53 Deteriorates Cardiac Energetics and Apoptotic Cell Death via TIGAR (TP53-Induced Glycolysis and Apoptosis Regulator)(PE075,Heart Failure (Pathophysiology) (M),Poster Session (English),The 73rd Annual Scientific Meeting of the Ja
- PJ-275 Overexpression of Tie2-promoted Activated Fibroblast Growth Factor Receptor-2 in Endothelial Cells Enhances Angiogenesis via Akt Signaling in Mice Hindlimb Ischemia(Regeneration (angionenesis/myocardial regeneration)-8 (M) PJ47,Poster Session (Japa
- FRS-036 In-hospital Prognostic Value of Crude Peak Creatine Kinase Measurement after Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction(FRS8,Novel Biomarkers and Pathophysiology of ACS (IHD),Featured Research Session (English),The
- Predictors of In-Hospital Outcome After Primary Percutaneous Coronary Intervention for Recurrent Myocardial Infarction
- Effects of Hospital Volume of Primary Percutaneous Coronary Interventions on Angiographic Results and In-Hospital Outcomes for Acute Myocardial Infarction
- OJ-204 Diminished Relation Between Hospital Volume of Primary PCI and In-Hospital Outcomes After AMI : Insights from the AMI-Kyoto Multi-Center Risk Study(Acute myocardial infarction, clinical (diagnosis / treatment)(04)(IHD),Oral Presentation (Japanese),
- OE-052 Is "Door-to-Balloon Time within 90 Minutes" Really the Gold Rule in Primary PCI for AMI in Japan?(Atherosclerosis, clinical(01)(IHD),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- FRS-005 Cause of Death in Patients with Acute Myocardial Infarction Presented Killip I/II : Insight from Database of Kyoto AMI Research Group(Acute Coronary Syndrome, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Predictors of In-Hospital Prognosis After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Requiring Mechanical Support Devices
- PE-394 p53 and SCO2 (Synthesis of Cytochrome c Oxidase 2) Augment the Progression of Diabetic Cardiomyopathy(PE066,Diabetes 2 (H),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- OE-232 p53 as a New Target of Cardiac Metabolism(Metabolism/Biochemistry/Energetics(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
- 1 Intracoronary Transplantation of Non-Expanded Peripheral Blood Mononuclear Cells in Patients with Acute Myocardial Infarction(Symposium 12 (SY-12) (M) Clinical Experiences of Regenerative Medicine in Cardiovascular Diseases,Special Program,The 72nd Annu
- Aldosterone Nongenomically Produces NADPH Oxidase-Dependent Reactive Oxygen Species and Induces Myocyte Apoptosis
- Intracoronary Transplantation of Non-Expanded Peripheral Blood-Derived Mononuclear Cells Promotes Improvement of Cardiac Function in Patients With Acute Myocardial Infarction
- PJ-477 PPARs Ligands Exhibit the Direct Anti-atherosclerotic Effect by Inhibiting ACE Expression in Streptozotocin-induced Diabetic Rat Aorta(Atherosclerosis, basic-5 (H) PJ80,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the
- Channel Blockers Reduce Angiotensin II-Induced Superoxide Generation and Inhibit Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Expression in Endothelial Cells
- Calcium Channel Blockades Exhibit Anti-Inflammatory and Antioxidative Effects by Augmentation of Endothelial Nitric Oxide Synthase and the Inhibition of Angiotensin Converting Enzyme in the N^G-Nitro-L-Arginine Methyl Ester-Induced Hypertensive Rat Aorta
- PJ-164 Additive Suppression of Mitochondria- and NADPH Oxidase-derived ROS by Combined Aldosterone and Angiotensin Receptor Blockers in Post-infarct Failing Hearts(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Sess
- DPJ-064 Chronic Administration of Recombinant Human Erythropoietin Exhibits Anti-inflammatory and Anti-oxidative Effects in Experimental Diabetic Rat Aorta beyond Hematopoiesis(DPJ11,Cardiovascular Pharmacology (Basic) (H),Digital Poster Session (Japanese
- FRS-072 Imatinib Induces Autophagy-Mediated Cell Death in Cardiac Myocytes(FRS15,Novel Molecular Mechanisms of Heart Failure 1 (M),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PJ-346 Pitavastatin Exhibited Direct Renoprotective Effects and Inhibited CYP11B2 and ACE Expression in the Uninephrectomized Streptozotocin-induced Diabetic Rat Kidney(Kidney/Renal circulation(06)(H),Poster Session(Japanese),The 72nd Annual Scientific Me
- PJ-112 Aldosterone Activates Apoptosis Signal-Regulating Kinase 1 (ASK-1) through Nongenomical ROS production and Induces Myocyte Apoptosis.(Heart failure, basic(05)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulatio
- PJ-053 Short-Term Caloric Restriction Improves Mitochondrial Oxidative Stress and Myocyte Apoptosis in Cardiac Pressure-Overload Hypertrophy(Cardiac hypertrophy, basic/clinical(02)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japa
- OJ-109 Chronic Administration of Recombinant Human Erythropoietin Ameliorates Renal Injury in Experimental Diabetic Rats beyond Hematopoiesis(Kidney/Renal circulation(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japanese Ci
- PJ-819 Erythropoietin Exhibits Renoprotective Effects in the Streptozotocin-Induced Diabetic Rats(Kidney/Renal circulation-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-764 Aldosterone Directly Induces Myocyte Apoptosis through NADPH Oxidase-Derived Reactive Oxygen Species(Development and differentiation-2, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-638 Histidine Exerts Anti-Hypertensive Effect via Central H3 Receptor and Increases the NOx Content in RVLM(Hypertension, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- PE-430 Spironolactone Suppresses Production of Mitochondrial Reactive Oxygen Species and Improves Cardiac Function in Post-infarct Failing Hearts(Heart failure, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-157 Spironolactone Reduced Renal Injury and Inhibited Hyperglycemia-Induced Overexpression of CYP11B2 in Uninephrectomized Streptozotocin-Induced Diabetic Rats(Kidney / Renal circulation-2, The 71st Annual Scientific Meeting of the Japanese Circulation
- PJ-401 Aldosterone Rapidly Activates MEK-ERK1/2 Signaling Pathway via Membrane Bound Mineralocorticoid Receptor(Heart failure, basic-5 (M) PJ68,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-322 Anti-Interleukin-6 Antibody Attenuates Left Ventricular Remodeling after Myocardial Infarction in Mice(Acute myocardial infarction, basic-2 (IHD) OJ54,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circu
- Ca Channel Blockades Show Anti-inflammatory and Anti-oxidative Effects by the Inhibition of ACE in L-NAME induced hypertensive Rat Aorta (Hypertension, Basic 5 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Spironolactone Modulates Expressions of Cardiac Mineralocorticoid Receptor and 11β-Hydroxysteroid Dehydrogenase 2 and Prevents Ventricular Remodeling in Post-Infarct Rat Hearts
- PJ-333 Impact of Clinical Path on Self Esteem to Modify Lifestyle in Patients Undergoing Cardiac Catheterization : Using Questionnaire about Lifestyle(PJ056,Preventive Medicine/Epidemiology/Education 2 (H),Poster Session (Japanese),The 73rd Annual Scienti
- In-Hospital Outcomes of Primary Percutaneous Coronary Interventions Performed at Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery
- PJ-699 Relation of Obesity to Acute Myocardial Infarction in Japanese Patients : differences in Gender and Age(Preventive medicine/Epidemiology/Education-5, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-252 Overexpression of Tie2-promoted Activated FGFR2 in Endothelium Enhances Angiogenesis and Induces Cardioprotection via Akt Signaling Pathway in Mice Myocardial Infarction(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japan
- OE-208 p53 Regulates Exercise Capacity in Mouse(Genetics/Genetically engineered models/Gene therapy-1(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Apoptotic Myocytes Generate Monocyte Chemoattractant Protein-1 to Draw the Activated Macrophages in Ischemia-Reperfused Rat Hearts
- Aldosterone Activates Calcineurin-Dependent Mitochondrial Apoptotic Pathway in Cultured Rat Cardiac Myocytes
- Amlodipine Inhibits Doxorubicin-lnduced Apoptosis in Neonatal Rat Cardiac Myocytes : Amlodipine Releases Nitric Oxide from Cultured Rat Cardiac Myocytes
- PJ-108 Overexpression of Tie2-promoted Activated FGFR2 in Endothelium Enhances Angiogenesis and Induces Cardioprotection via Akt Signaling Pathway in Mice Myocardial Infarction(Growth factor/Cytokine(02)(H),Poster Session(Japanese),The 72nd Annual Scienti
- Beneficial Effects of Reperfusion Therapy in Elderly or Super-Elderly Patients with Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 8 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PJ-298 Multi-center Investigation of Chronic Mortality of Myocardial Infarction in the Primary Angioplasty Era(Acute myocardial infarction, clinical (diagnosis/treatment)-8 (IHD) PJ50,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meetin
- OJ-281 Characteristics and Outcome of Out-of-hospital Cardiac Arrest Using Utstein System-Kyoto Experience(Emergency care-2 (H) OJ47,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
- Incidence and Prognosis of AMI Patients with Cardiac Rupture from AMI-Kyoto Multi-Center Risk Study (Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 6 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-157 Spironolactone Modulates Expression of Cardiac Mineralocorticoid Receptor and Prevents Myocyte Apoptosis and Ventricular Remodeling in Post-Infarcted Rat Hearts(Chronic coronary heart disease/Remodeling-2 (IHD) OJ27,Oral Presentation (Japanese),The
- Echocardiographic Diagnosis of Pulmonary Vein Varix
- PJ-541 Mitochondrial KATP Channel Openers Attenuate Ca^-induced Mitochondrial Death Signaling Pathway in Cardiac Mitochondria(Myocardial Ischemia-Reperfusion, Basic and Clinical 3 (M) : PJ91)(Poster Session (Japanese))
- PJ-374 Aldosterone Increases Intrcellular Calcium Level and Myocyte Apoptosis through Calcineurin-Dependent Pathways(Apoptosis/Necrosis/Regeneration 1 (M) : PJ63)(Poster Session (Japanese))
- OE-157 AMI-Kyoto Multi-Center Risk Study for In-Hospital Mortality Assessment(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 6 (IHD) : OE19)(Oral Presentation (English))
- PJ-790 Cardioprotective Action of Interleukin-1 β in Adaptation to Cardiac Pressure-overload Stress by Activation of IGF-1/PI3K/Akt Signaling Pathway(Growth factor/Cytokine-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- ISCHEMIC PRECONDITIONING IMPROVES GLUTATHIONE STRESS AGAINST ISCHEMIA-REPERFUSION INJURY IN RAT HEARTS.
- Nicorandil Regulates Bcl-2 Family Proteins and Inhibits Mitochondrial Permeability Transition in Rat Hypoxic Myocytes (Apoptosis/Necrosis/Regeneration 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Cardiac Sarcoidosis Mimicking Right Ventricular Dysplasia
- Predictors of nonoptimal coronary flow after primary percutaneous coronary intervention with stent implantation for acute myocardial infarction
- Influence of previous myocardial infarction site on in-hospital outcome after primary percutaneous coronary intervention for repeat myocardial infarction
- Clinical manifestations and effects of primary percutaneous coronary intervention for patients with delayed pre-hospital time in acute myocardial infarction
- OE-150 Importance to Shorten Door to Balloon Time in Primary Angioplasty for Acute Myocardial Infarction(Acute Myocardial Infarction, Clinical (Diagnosis/Treatment) 5 (IHD) : OE18)(Oral Presentation (English))